Form 4: Ventyx Biosciences Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Christopher Krueger, Chief Business Officer of Ventyx Biosciences, sold 1,651 shares of common stock to cover tax obligations related to vesting restricted stock units.
Summary
- On April 2, 2024, Christopher Krueger, the Chief Business Officer of Ventyx Biosciences, sold 1,651 shares of the company's common stock.
- The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units.
- The shares were sold at a weighted average price of $5.4036, with individual sales occurring in the price range of $5.28 to $5.4062.
- Following the transaction, Krueger still beneficially owns 284,999 shares of Ventyx Biosciences common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to an executive's stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading activity and are required by the SEC to ensure transparency in the market. This sale appears to be related to tax obligations, which is a common reason for executives to sell shares.
Key Dates
| Date | Description |
|---|---|
| 04/02/2024 | Date of the stock sale transaction. |
| 04/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.